Serum cystatin C levels are associated with coronary artery disease and its severity

Gan-nan Wang1, Kai Sun1, De-liang Hu1

  • 1Department of Emergency, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, PR China.

Clinical Biochemistry
|August 2, 2014
PubMed

Insights

Elevated serum cystatin C levels are linked to coronary artery disease (CAD) presence and severity in individuals with normal kidney function. This suggests cystatin C may aid in CAD diagnosis and severity assessment.

Area of Science:

  • Cardiology
  • Biomarkers
  • Renal Function

Background:

  • Serum cystatin C is a known predictor of cardiovascular events.
  • Its role in determining coronary artery disease (CAD) presence and severity requires further elucidation.

Purpose of the Study:

  • To evaluate the association between serum cystatin C levels and the presence of CAD.
  • To assess the correlation of cystatin C with the severity of CAD in patients with normal renal function.

Main Methods:

  • Cross-sectional study of 936 subjects (714 with CAD, 222 without) based on coronary angiography.
  • Serum cystatin C measured via particle-enhanced immunoassay.
  • Analysis of cystatin C levels against CAD presence, number of stenotic vessels, and Gensini score.

Main Results:

  • Significantly higher serum cystatin C in CAD patients (P<0.001).
  • Cystatin C levels increased with coronary vessel involvement and Gensini score (P<0.001).
  • Independent correlation of cystatin C with CAD presence (P=0.023) and positive correlation with Gensini score (P=0.010).

Conclusions:

  • Elevated serum cystatin C is significantly associated with CAD presence and severity in patients with normal renal function.
  • Cystatin C may serve as a valuable diagnostic marker and severity indicator for CAD.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
958
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
671